Q32 Bio Inc. balance sheet

At the end of fiscal 2025, Q32 Bio Inc. had total assets of $61.8m, total liabilities of $19.8m and shareholders' equity of $42.0m. It held $48.3m in cash against $9.7m of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Q32 Bio Inc.: balance sheet, annual
Fiscal year	2018Dec 2018	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Cash and equivalents	38	54	217	108	34	26	78	48
Total current assets	222	267	220	192	181	29	82	55
Total assets	259	311	264	212	228	47	92	62
Accounts payable	16	3	5	2	1	3	3	1
Deferred revenue (current)	1	1	6	3	1	0	—	—
Total current liabilities	23	12	23	17	23	14	16	11
Total debt	0	0	0	0	0	39	13	10
Total liabilities	63	52	68	42	50	119	87	20
Shareholders' equity	196	259	196	170	−131	−183	6	42
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	309	111	—	—
Shares outstanding	—	45m	50m	57m	57m	—	—	13m

US$ millions unless shown otherwise. Fiscal quarters.

Q32 Bio Inc.: balance sheet, quarterly
Quarter	2023 Q1Mar 2023	2023 Q2Jun 2023	2023 Q3Sept 2023	2023 Q4Dec 2023	2024 Q1Mar 2024	2024 Q2Jun 2024	2024 Q3Sept 2024	2024 Q4Dec 2024
Total current assets	154	131	107	29	138	112	94	82
Total assets	198	169	140	47	152	124	105	92
Accounts payable	4	3	8	3	5	2	1	3
Deferred revenue (current)	0	0	0	0	—	—	—	—
Total current liabilities	19	23	25	14	33	17	14	16
Total liabilities	46	50	52	119	104	91	86	87
Shareholders' equity	−137	−143	−156	−183	49	34	18	6
Non-controlling interests and other (assets − liabilities − equity)	289	262	245	111	—	—	—	—
Shares outstanding	58m	58m	58m	—	12m	12m	12m	12m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Q32 Bio Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Q32 Bio Inc.